According to Rani Therapeutics's latest financial reports the company has $48.53 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $98.48 M | -16.15% |
2021-12-31 | $0.11 B | 60.77% |
2020-12-31 | $73.05 M | 341.81% |
2019-12-31 | $16.53 M |